Health
Vaccines for SARS coronavirus 2 and the new normal in vaccinology – Wiley
Click on the article title to read more.
Severe acute respiratory syndrome coronavirus 2 (SARSCoV2) causes an acute infection that is controlled by the immune response. The virus has a dominant surface protein that is highly immunogenic and it can be presumed that neutralising antibodies will prove to be the correlate of protection, supported by cellmediated immunity.1 It should therefore be straightforward to produce a vaccine against this novel virus.
This perspective has turned out to be true, but it is the pace with which the vaccines…
-
Business18 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News17 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News14 hours agoTips to improve engagement – Proctor
-
General12 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline